Sharma et al present the prospective comprehensive analysis of 60 patients with NSCLC: "Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non–Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy​". Each patient underwent dynamic sequential whole-body 18F-FDG with quantitative perfusion PET tumor analysis. Authors concluded that baseline MTV and TLG of primary tumor or whole-body tumor lesions are reliable prognostic markers of OS in NSCLC patients undergoing platinum-based chemotherapy. However, other SUVmax, average SUV, tumor-to-background ratio and dynamic PET/CT parameters have no prognostic value in this cohort.​

Current Issue

Prediction of Posthepatectomy Liver Failure Proposed by the International Study Group of Liver Surgery: Residual Liver Function Estimation With 99mTc-Galactosyl Human Serum...

Mizutani, Yoichi; Hirai, Toshinori; Nagamachi, Shigeki; More

Clinical Nuclear Medicine. 43(2):77-81, February 2018.

1 2 3 4 5